In agreement with previous findings in a mouse model of multiple sclerosis [18], our results therefore suggest that dysregulation of CD163, CD206 and IL-10 impacts the resolution of organ-specific inflammation. This evidence concerns the gene MRC1 and multiple sclerosis.